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Background: Psychiatric morbidity is highly prevalent in the primary health care settings and it may be related to autoimmune
thyroid disease (AITD). The aim of this study was to evaluate the impact of thyroid immunity, evident by hypo-echoic thyroid
ultrasound pattern, on prevalence of depression and anxiety in a primary care setting.
Methods: In a cross-sectional design, 504 consecutive primary care patients were invited to the study and 474 patients completed
the study. They were screened for depression and anxiety using the Hospital Anxiety and Depression Scale (HADS), were
interviewed for affective disorders using the Mini International Neuropsychiatric Interview, and were evaluated by
ultrasonographic imagining of the thyroid gland.
Results: Among patients with hypo-echoic thyroid (n=122) prevailed women and those patients were older than patients with
normo-echoic thyroid (n=352). Women, but not men, with hypo-echoic thyroid compared to those with normo-echoic thyroid had
higher scores on the anxiety subscale of the HADS (p=0.03). Among women with hypo-echoic thyroid, only those pre-menopause,
but not those post-menopause, had greater prevalence of high scores on the depression subscale of the HADS (p=0.02) and a
greater likelihood of using psychiatric medications (p=0.001).
Limitations: Lack of cytological evaluation of the thyroid gland; lack of serum thyroid antibodies concentrations; and lack of
thyroid hormone concentrations.
Conclusions: Thyroid immunity is related to mood symptoms in primary care patients. These effects are gender specific and in
women, they are most evident before menopause.
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Depression and anxiety disorders are highly pre-
valent in the general population (Kessler et al., 1994) as
well as in the primary health care settings (Sartorius et
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mood disorders and thyroid immunity has been demon-
strated in community samples (Pop et al., 1998; Carta
et al., 2004), in an endocrine patient population
(Bunevicius et al., 2005) and in psychiatric patients
(Haggerty et al., 1997; Fountoulakis et al., 2004; Kupka
et al., 2002). These studies suggest that an autoimmune
thyroid disease (AITD), even without clinical or
subclinical thyroid dysfunction, is related to mood and
anxiety disorders. However, this has never been studied
in an unselected medical population, such as in primary
health care patients.
There are two major forms of AITD, autoimmune
thyroiditis and Graves' disease. AITD is an autoimmune
process characterized by the lymphocytic infiltration of
the thyroid gland and by the presence of auto-antibodies
against the thyroid antigens (Utiger, 1991). Results of
fine needle aspiration biopsy as well as results of
autopsy show that up to 40% of women have AITD
evident by lymphocytic infiltration of the thyroid gland
(Weetman, 2004). Assessment of thyroid antibodies in
peripheral circulation show that the prevalence of AITD
is close to 17% in the female population (Knudsen et al.,
1999). In clinical practice, a diagnosis of AITD is
usually based on the presence of thyroid antibodies in
serum; however, that approach could miss some patients
with AITD, because not all AITD patients are positive
for thyroid antibodies in peripheral circulation, includ-
ing those with thyroid dysfunction (Dayan and Daniels,
1996). In this regard, hypo-echoic ultrasound pattern of
the thyroid gland that is related to lymphocytic
infiltration of thyroid gland, assessed by ultrasound
evaluation, may serve as a sensitive indicator of AITD
(Hayashi et al., 1986; Marcocci et al., 1991; Rago et al.,
2001). It was demonstrated in recent studies that an
abnormal hypo-echoic thyroid ultrasound pattern is
highly indicative for AITD (Raber et al., 2002; Pedersen
et al., 2003; Smutek et al., 2003).
The aim of this study was to evaluate the association
of thyroid immunity, evident by hypo-echoic thyroid
ultrasound pattern, with depression and with anxiety
symptoms, in primary care patients.
2. Subjects and method
2.1. Subjects
Five hundred and four primary care patients
consecutively admitted during a 4-week period to the
primary health care medical center in Kaunas, Lithua-
nia were invited to participate in the study. Patients
with uncompensated hypothyroidism or uncompen-sated hyperthyroidism evident by abnormal thyroid
hormone or/and thyroid stimulating hormone concen-
tration; and patients without thyroid tissue were
excluded from the study. Four hundred seventy-four
patients completed the study. All patients gave written
informed consent. The study and its consent procedures
were approved by the Regional Committee of Ethics in
Biomedical Research at the Kaunas University of
Medicine, Kaunas, Lithuania.
The mean age of the study population was 52 years,
ranging from 18 to 89 years, and 348 (73%) were
women. One hundred ninety-five study women (56%)
were post-menopausal, based on self-report absence of
menses for at least 12 months. Sixty-seven patients
(14%) had a history of endocrine disease; sixty-eight
patients (14%) had a history of mental disorder. Eighty-
four patients (18%) used psychotropic medication,
mostly benzodiazepines, 69 patients (15%); no patient
used lithium. Six women had diagnoses of hypothyroid-
ism and were treated with L-thyroxine.
2.2. Methods
After visiting their general practitioner all study
patients were interviewed for demographic data and
general health status, relevant data from medical
documentation were collected. Patients were asked to
fill out a standard psychiatric questionnaire and were
interviewed for psychiatric diagnoses by the same trained
general practitioner (JP), and ultrasound evaluation of the
thyroid glandwas performed by the same endocrinologist
(NM). The ultrasound reader was blind to the psychiatric
diagnoses and the person performing the psychiatric
evaluation was blind to the echoic thyroid pattern.
All patients were assessed for depression and anxiety
symptoms using the Hospital Anxiety and Depression
Scale (HADS) (Zigmond and Snaith, 1983). The HADS
is comprised of 14 items scored from 0 to 3 to which
patients respond based on their experience over the past
week. Seven items relevant to anxiety comprise a
subscale for anxiety with a score range from 0 to 21;
seven other items comprise a subscale for depression
with the same score range. A score of 8–10 suggests,
and a score of 11 or more indicates, the presence of
depressive disorder or anxiety disorder. The HADS was
constructed for self-administration by inpatients and
outpatients in non-psychiatric clinical settings.
All study patients were interviewed for mental
disorders using mood and anxiety modules of the
Mini-International Neuropsychiatric Interview (MINI)
(Sheehan et al., 1998). These modules assess current
diagnoses of major depression and anxiety disorders,
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anxiety. The MINI is a structured clinical interview to
assess diagnoses using the criteria of the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition
Text Revision (DSM-IV-TR) (APA, 2000) and the
International Statistical Classification of Diseases, 10th
Revision (ICD-10) Classification of Mental and Beha-
vioural Disorders (WHO, 1992).
Thyroid gland ultrasonographic evaluation was
performed with a real-time scanner equipped with
5 MHz liner transducer with water pillow (SSD-210
Dx, Aloka, Japan). Normal echoic thyroid pattern was
considered when the density of the thyroid gland was
similar to submandibular gland and hypo-echoic to neck
muscles; hypo-echoic thyroid pattern was considered
when the density of the thyroid gland was hypo-echoic
to submandibular gland and hypo-echoic or isohypo-
echoic to neck muscles (Raber et al., 2002).
3. Statistical analysis
All continuous data are presented as means±standard
deviations, all categorical data as number and percent.
First we examined whether demographic data and
measurements of health status are associated with
gender. Comparisons between men and women on
categorical variables were performed using a two-tailed
χ2 analysis, comparisons on continuous data were
performed using non-paired two-tailed t-tests. Next we
investigated whether scores of depression and anxietyFig. 1. Differences of scores on subscales of depression and anxiety of the
thyroid pattern in 348 female primary care patients (adjusted for age).were associated with an echoic thyroid pattern in the
total sample of men, and in the total sample of women.
General linear multivariate models were employed for
these comparisons where scores on subscales of anxiety
and depression of the HADS were used as dependent
variables, echoic thyroid pattern was used as the
independent factor, and age was used as covariate.
Eventually the prevalence of mental disorders and the
use of psychiatric medication were compared in two
subgroups of women with respect to their menopausal
status. Comparisons between women with a normo-
echoic thyroid pattern and those with a hypo-echoic
thyroid pattern were performed using a two-tailed χ2
analysis separately in pre-menopausal women and in
post-menopausal women. A probability level of p<0.05
was taken as significant. The SPSS 12.0 for windows
program was used for data analyses.
4. Results
Among 474 primary care patients 56 (12%) had
scores on the subscale of depression of the HADS
higher then 10, indicating a depressive disorder; 121
(26%) had scores on the subscale of anxiety higher then
10, indicating an anxiety disorder; 169 (36%) had
specific MINI diagnoses of depression or anxiety
disorder. Ultrasonographic evaluation of the thyroid
gland revealed that 122 patients (26%) had a hypo-
echoic thyroid pattern, indicating AITD. Women
compared to men had higher scores on the subscale ofHospital Anxiety and Depression Scale (HADS) in relation to echoic
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subscale of anxiety (8.1±4.4 vs.6.7±4.0; p=0.001) of
the HADS. According to the MINI women had higher
prevalence of generalized anxiety disorder (28% vs.
19%; p=0.04) and higher total prevalence of depression
or anxiety disorder (38% vs. 29%; p=0.05). On
ultrasonographic evaluation women compared to men
had a higher prevalence of a hypo-echoic thyroid pattern
(30% vs.14%; p=0.001).
Because there were significant gender differences
in endocrine and mental status, data pertaining to
thyroid immunity were analyzed separately for men
and for women. Men and women with hypo-echoic
thyroid compared to those with normo-echoic thyroid
were significantly older (61±14 vs. 51±20; p=0.05;
and 64±14 vs. 47±20; p<0.001; respectively), so
other comparisons were adjusted for age. Fig. 1 shows
that women with a hypo-echoic thyroid compared to
women with normo-echoic thyroid had higher scores
on the anxiety subscale of the HADS (9.0±4.6 vs.
7.8±4.4; p=0.03). Scores on the depression subscale
of the HADS also were higher among women with a
hypo-echoic thyroid; however, this difference lost
statistical significance after adjusting for age. Echoic
thyroid pattern was not associated with the HADS
scores in men nor with the prevalence of MINI
diagnoses in men or in women.
When women were divided into two groups in
relation to their menopausal status, only pre-menopausal
women with hypo-echoic thyroid compared to those
with normo-echoic thyroid had higher prevalence of use
of psychiatric medication (31% vs. 6%; p=0.001), andTable 1








Depression>10 4 (3) 3 (19)
Anxiety>10 27 (20) 6 (38)
MINI diagnoses
Major Depression 21 (15) 3 (19)
Anxiety disorders
Panic disorder 6 (4) 2 (13)
Social phobia 8 (6) 2 (13)
Generalized anxiety 30 (22) 5 (31)
Depression or
Anxiety disorder
40 (29) 8 (50)
Use of psychiatric
medication
8 (6) 5 (31)
Use of benzodiazepines 6 (4) 4 (25)higher prevalence of depression according to the HADS
(19% vs. 3%; p=0.02) but there were no difference in
the prevalence of specific mental disorders diagnosed by
MINI (Table 1). However, prevalence of total MINI
depression or anxiety disorders tended to be higher
(50% vs. 29%; p=0.09) in pre-menopausal women with
hypo-echoic thyroid compared to those with normo-
echoic thyroid. There were no significant differences in
regards to echoic thyroid pattern in the prevalence of
mood disorders or the use of psychiatric medication in
post-menopausal women.
5. Discussion
The results of this study indicate that thyroid
autoimmunity, evaluated by a relatively simple, cost
effective but reliable technique, ultrosonographic ima-
ging of the thyroid gland, is associated with mood
symptoms in primary health care patients, especially in
pre-menopausal women. This observation corresponds
to findings from other studies on the relationship
between thyroid autoimmunity and mood disorders
where thyroid immunity was measured by the assess-
ment of thyroid antibodies in peripheral circulation
(Carta et al., 2004; Haggerty et al., 1997; Kupka et al.,
2002). Indeed, recent findings (Pedersen et al., 2003;
Rago et al., 2001; Smutek et al., 2003) suggest that
thyroid hypo-echogenicity found by ultrasonographic
evaluation of the thyroid gland is a strong predictor of
AITD and there is a close correlation between this
marker of the AITD and the presence of thyroid







0.02 24 (22) 19 (22) 0.9
0.2 33 (31) 35 (40) 0.09
0.7 32 (30) 28 (32) 0.8
0.2 2 (2) 2 (2) 0.8
0.3 2 (2) 1 (1) 0.7
0.4 35 (32) 28 (32) 0.9
0.09 46 (43) 39 (44) 0.9
0.001 27 (26) 20 (23) 0.7
0.002 22 (21) 17 (20) 0.8
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the association between thyroid immunity and mood or
anxiety symptoms in primary care female patients,
especially in pre-menopausal women. These data are
consistent with the report of Pop et al. (1998) who
together with colleagues in their community studied 583
randomly selected pre-menopausal women and found
that those with elevated thyroid antibody concentrations
were especially vulnerable for depression, whereas post-
menopausal status and thyroid hormone status did not
increase risk of depression. In a similar way it was
demonstrated in the post-partum period that women who
had a higher serum thyroid antibody concentration post-
partum (Harris et al., 1992) or during gestation (Kuijpens
et al., 2001) had a higher prevalence of post-partum
depression. In combination with our results, these
findings, taken together, suggest a role of the female
sex hormones in the association of thyroid autoimmune
process and mood or anxiety disorders. While this
remains an area of further inquiry, evidence that thyroid
hormone concentrations (Girdler et al., 1995, 2004) as
well as thyroid gland size (Hegedus et al., 1986) vary
with phase of the menstrual cycle in pre-menopausal
women provide partial support for this supposition.
In our study, it is curious to note that the self-rating
instrument to measure symptoms of depression and
anxiety, the HADS, revealed associations between mood
symptoms and thyroid immunity in pre-menopausal
women. However, we found no statistically significant
differences in the prevalence of specific mood and
anxiety disorders assessed by structured diagnostic
interview in relation to thyroid echogenicity. The possible
explanation for this inconsistency may be related to the
treatment of mental symptoms. Indeed, pre-menopausal
women with hypo-echoic thyroid pattern were treated
more frequently with psychotropic medication, including
benzodiazepines, in comparison to women with normo-
echoic thyroid. This may have decreased the incidence of
patients that fulfill criteria for specific mental disorders in
the hypo-echoic thyroid group.
AITD is frequently related to thyroid dysfunction and
it is suggested that even marginal thyroid dysfunction
may be associated with mood and anxiety disorders
(Prange, 1998). However, a large epidemiological study
found no statistical association between clinical or
subclinical thyroid dysfunction, and the presence of
depression or anxiety disorders in a large unselected
population (Engum et al., 2002). Moreover, several
studies that reported an association between depression
and increased levels of thyroid antibodies found that
depression was not related to thyroid dysfunction (Harris
et al., 1992; Pop et al., 1998; Kuijpens et al., 2001). Arecent study of Grabe et al. (2005) found that a general
population of women with AITD, diagnosed by hypo-
echoic thyroid pattern and by the presence of thyroid
antibodies in serum, showed higher scores of anxiety
independently from their thyroid function. It may be that
it is not marginal thyroid dysfunction, but rather thyroid
autoimmune processes, frequently responsible for this
dysfunction (Bunevicius et al., 1994, 1996), that are
responsible for co-morbidity with mood disorders. In our
study we did not assess thyroid axis hormone concentra-
tions and did not address this important question directly.
However, our findings, together with findings of others
suggest that thyroid immunity per se may be an
important predictor of mood disorders.
Involvement of thyroid immunity in brain function-
ing was reported by several neuro-imagining studies,
demonstrating a higher prevalence of brain perfusion
abnormalities in euthyroid patients with autoimmune
thyroiditis (Zettinig et al., 2003; Piga et al., 2004) and
higher levels of anxiety and depression in these patients
(Zettinig et al., 2003). These brain perfusion abnorm-
alities are similar to those observed in Hashimoto's
encephalopathy (Chong et al., 2003) and may suggest a
higher than expected involvement of the brain in AITD.
Findings from this study obtained from an unselected
primary care population, along with other studies,
provide evidence that an autoimmune thyroid process
per se may be related to mood and anxiety disorders.
A full understanding of the relationship between thyroid
autoimmunity and mental functioning awaits a full
description. Further studies on the involvement of
thyroid immunity in mental disorders as well as on the
involvement of mental disorders in euthyroid patients
with autoimmune thyroid disease are needed. This
possibility can be investigated by the use of different
techniques for the evaluation of thyroid autoimmunity:
by the measurement of serum thyroid antibodies; by the
cytological assessment of thyroid tissue, or by the
ultrasonographic evaluation of the thyroid gland.
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